• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by AdaptHealth Corp.

    8/19/24 7:08:25 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care
    Get the next $AHCO alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001076341
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    AdaptHealth Corp.
    SEC File Number
    001-38399
    Address of Issuer
    220 West Germantown Pike, Suite 250
    Plymouth Meeting
    PENNSYLVANIA
    19462
    Phone
    610-630-6357
    Name of Person for Whose Account the Securities are To Be Sold
    Richard A. Barasch
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Former Affiliate

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    J.P. Morgan Securities LLC
    390 Madison Avenue
    6th Floor
    New York � NY � 10017
    10235107058.113446984708/19/2024
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock07/01/2023CEO RSU'sIssuerCheckbox not checked1023507/01/2023Compensation as Interim CEO

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Richard Barasch
    C/O Issuer
    220 West Germantown Pike, Suite 250
    Plymouth Meeting � PA � 19462
    Common Stock08/15/202425614256180.98

    144: Remarks and Signature

    Remarks
    Date of Notice
    08/19/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Richard A. Barasch

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $AHCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AHCO

    DatePrice TargetRatingAnalyst
    1/8/2024$14.50 → $8.00Buy → Hold
    Jefferies
    11/8/2023$9.50 → $6.50Neutral → Underperform
    BofA Securities
    5/10/2023$28.00 → $11.30Buy → Hold
    Deutsche Bank
    5/10/2023$18.00 → $11.00Buy → Hold
    Stifel
    5/9/2023$21.00 → $12.00Buy → Neutral
    BofA Securities
    3/8/2022$31.00 → $26.00Outperform
    RBC Capital
    3/2/2022$32.00 → $24.00Outperform
    SVB Leerink
    2/18/2022$35.00 → $32.00Outperform
    SVB Leerink
    More analyst ratings

    $AHCO
    Leadership Updates

    Live Leadership Updates

    See more
    • AdaptHealth Corp. Announces Appointment of Russell Schuster as Chief Commercial Officer

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024. In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight ye

      12/3/24 8:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Appoints Diana Nole to Board of Directors

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced the appointment of Diana Nole to the Board of Directors, effective October 16, 2024. "We are thrilled to welcome Diana to the AdaptHealth Board of Directors. Her extensive leadership experience in the healthcare technology sector caught our eye and we soon discovered that her decisive, resourceful leadership style and expertise in business transformation aligned perfectly with our current goals as an organization," said Dale Wolf, Chairman of the AdaptHealth B

      10/17/24 8:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer

      Advantage Healthcare Holdings ("Advantage" or the "Company"), a regional leader in providing patient-centered healthcare through managing and operating Comprehensive Outpatient Rehabilitation Facilities and Sleep Centers, announced that its Board of Directors has named Dinak (Dino) Nair as its Chief Executive Officer. Mr. Nair assumed leadership of the Company from the prior CEO, Ryan Tong, on September 1, 2024. Mr. Nair brings over 20 years of business experience, with more than a decade as a mission-driven leader growing businesses in the healthcare market, especially in homecare, home medical equipment, diagnostic laboratory, and health system partnerships. Mr. Nair most recently served

      9/25/24 11:19:00 AM ET
      $AHCO
      $LH
      Medical/Nursing Services
      Health Care
      Medical Specialities

    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdaptHealth Corp. Announces First Quarter 2025 Results

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi

      5/6/25 7:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-5172 (Domestic) or (203) 518-9856 (International) When prompted, reference Conference ID: AHCO1Q25 Webcast registration: Click Here Following the live

      4/21/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. to Participate in Upcoming Investor Conferences

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Jefferies Value-Based Healthcare Summit, being held in Miami, on Monday, March 10, 2025, including a fireside chat at 3:45pm ET. The Leerink Partners Global Healthcare Conference 2025, being held in Miami, on Tuesday, March 11, 2025, including a fireside chat at 11:20am ET. The webcast link will be available on the Company's website, www.adapthealth.com under "Investor Relations.

      3/6/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdaptHealth downgraded by Jefferies with a new price target

      Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously

      1/8/24 9:03:40 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth downgraded by BofA Securities with a new price target

      BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously

      11/8/23 6:22:25 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously

      5/10/23 6:33:54 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

      SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      11/14/24 9:03:31 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by AdaptHealth Corp.

      SC 13G - AdaptHealth Corp. (0001725255) (Subject)

      11/13/24 9:30:46 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

      SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      11/12/24 1:30:20 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Financials

    Live finance-specific insights

    See more
    • AdaptHealth Corp. Announces First Quarter 2025 Results

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025. First Quarter Results and Highlights All comparisons are to the quarter ended March 31, 2024. Net revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%. Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million. Adjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%. Cash flow from operations was $95.5 mi

      5/6/25 7:00:00 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2025 financial results before the opening of the financial markets on Tuesday, May 6, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 343-5172 (Domestic) or (203) 518-9856 (International) When prompted, reference Conference ID: AHCO1Q25 Webcast registration: Click Here Following the live

      4/21/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth Corp. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

      AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2024 financial results before the opening of the financial markets on Tuesday, February 25, 2025. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 245-3047 (Domestic) or (203) 518-9765 (International) When prompted, reference Conference ID: AHCO4Q24 Webcast registration: Clic

      2/4/25 4:05:00 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by AdaptHealth Corp.

      SCHEDULE 13G - AdaptHealth Corp. (0001725255) (Subject)

      5/15/25 9:33:34 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by AdaptHealth Corp.

      SCHEDULE 13G/A - AdaptHealth Corp. (0001725255) (Subject)

      5/12/25 10:24:40 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by AdaptHealth Corp.

      10-Q - AdaptHealth Corp. (0001725255) (Filer)

      5/6/25 4:29:45 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care

    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Commercial Officer Schuster Iii Russell E. was granted 99,006 shares (SEC Form 4)

      4 - AdaptHealth Corp. (0001725255) (Issuer)

      2/4/25 4:32:22 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • CLO and General Counsel Rew Richard W. Ii was granted 48,409 shares (SEC Form 4)

      4 - AdaptHealth Corp. (0001725255) (Issuer)

      2/4/25 4:30:31 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • Chief Technology Officer Prast Albert A. was granted 62,932 shares, increasing direct ownership by 20% to 379,458 units (SEC Form 4)

      4 - AdaptHealth Corp. (0001725255) (Issuer)

      2/4/25 4:29:15 PM ET
      $AHCO
      Medical/Nursing Services
      Health Care